Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.52 |
| ▸ | MAOA | P21397 | 2/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.52 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.52 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 3/20 | 0.43 |
| ▸ | NOS3 | P29474 | 1/20 | 0.43 |
| ▸ | NOS1 | P29475 | 1/20 | 0.43 |
| ▸ | NOS2 | P35228 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1466263 | 0.98 | SLC6A2 (0.50) | SLC6A2TAAR1SLC6A4MAOASLC6A3 | |
| SCHEMBL560907 | 0.81 | PPARG (0.45) | SLC6A2TAAR1SLC6A4MAOASLC6A3 | |
| SCHEMBL10899765 | 0.81 | L3MBTL1 (0.47) | SLC6A2TAAR1SLC6A4MAOASLC6A3 | |
| SCHEMBL9355886 | 0.79 | SLC6A2 (0.45) | SLC6A2TAAR1SLC6A4MAOASLC6A3 | |
| SCHEMBL11702272 | 0.78 | CYP2D6 (0.46) | SLC6A2TAAR1SLC6A4MAOASLC6A3 | |
| SCHEMBL9214208 | 0.78 | SLC6A2 (0.55) | SLC6A2TAAR1SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL24013069 | 0.77 | IDO1 (0.43) | SLC6A2TAAR1SLC6A4MAOASLC6A3 | |
| SCHEMBL4850434 | 0.77 | PPARG (0.42) | SLC6A2TAAR1SLC6A4MAOASLC6A3 | |
| SCHEMBL7215558 | 0.77 | PPARG (0.42) | SLC6A2TAAR1SLC6A4MAOASLC6A3 | |
| SCHEMBL27690898 | 0.77 | PPARG (0.42) | SLC6A2TAAR1SLC6A4MAOASLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11370736-B2 | Synthesis of fluoro hemiacetals via transition metal-catalyzed fluoro ester and carboxamide hydrogenation | TRIAD NATIONAL SECURITY, LLC (US) | 2022-06-28 | — | — | US | disclosed |
| US-20200308089-A1 | SYNTHESIS OF FLUORO HEMIACETALS VIA TRANSITION METAL-CATALYZED FLUORO ESTER AND CARBOXAMIDE HYDROGENATION | U.S. DEPARTMENT OF ENERGY | 2020-10-01 | — | — | US | disclosed |
| US-8518368-B2 | Method for the production of hydrogen from ammonia borane | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2013-08-27 | — | — | US | disclosed |
| US-20110070152-A1 | METHOD FOR THE PRODUCTION OF HYDROGEN FROM AMMONIA BORANE | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2011-03-24 | — | — | US | disclosed |
| EP-2158154-A1 | METHOD FOR THE PRODUCTION OF HYDROGEN FROM AMMONIA BORANE | Kanata Chemical Technologies Inc. (CA) | 2010-03-03 | — | — | EP | disclosed |
| WO-2008141439-A1 | METHOD FOR THE PRODUCTION OF HYDROGEN FROM AMMONIA BORANE | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2008-11-27 | — | — | WO | disclosed |
| EP-0360637-B1 | Benzofuran compounds, process for their preparation, pharmaceutical and cosmetic compositions containing them and use of these compositions | OREAL (FR) | 1994-05-04 | — | — | EP | disclosed |
| EP-0260162-B1 | BICYCLIC AROMATIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINES | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA - CIRD GALDERMA Groupement d'Intérêt Economique dit: (FR) | 1990-11-14 | — | — | EP | disclosed |
| WO-1986006064-A1 | NAPHTHALENIC DERIVATIVES WITH RETINOID ACTIVITY, PREPARATION PROCESS THEREOF AND MEDICINAL AND COSMETIC COMPOSITIONS CONTAINING THEM | L'OREAL (FR) | 1986-10-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200308089-A1 | SYNTHESIS OF FLUORO HEMIACETALS VIA TRANSITION METAL-CATALYZED FLUORO ESTER AND CARBOXAMIDE HYDROGENATION | FH, HIRA, HNF4A | SLC6A2 2435/4885TAAR1 2454/4885SLC6A4 1107/4885 |
| US-11370736-B2 | Synthesis of fluoro hemiacetals via transition metal-catalyzed fluoro ester and carboxamide hydrogenation | FH, HIRA, HNF4A | SLC6A2 2435/4885TAAR1 2454/4885SLC6A4 1107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.